FORMULARY WATCH

OPIOIDS

TODAY'S HEADLINES

FDA panel green lights Probuphine for opioid addiction

FDA advisers recommended approval of the first long-acting, subdermal buprenorphine implant (Probuphine, Titan Pharmaceuticals, Inc. and Braeburn Pharmaceuticals) for the maintenance treatment of opioid addiction. Read more

FDA approves new indication for Hib vaccine

FDA has approved an expanded age indication for Hib vaccine (Hiberix, GlaxoSmithKine). Read more

CONTINUING PHARMACY EDUCATION

LAW: Primer on biosimilar agents

This month's CE activity is open for pharmacists and pharmacy technicians, "LAW: Primer on biosimilar agents." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE law credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

Drugmakers debate pricing, legislation

Pharmaceutical companies are battling state legislation that would require state programs such as Medicaid to pay no more than other Federal government programs for drugs. Details

January 20, 2016

Opioid addiction treatment in the ED better than referrals

Formulary managers can help improve vaccination rates

Click to contact the editorial team. Click to contact the sales team.

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us